amantadine has been researched along with Anxiety in 12 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amantadine was not superior to placebo." | 6.72 | Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial. ( Garssen, MP; Jacobs, BC; Merkies, IS; Schmitz, PI; van der Meché, FG; van Doorn, PA, 2006) |
| "Nineteen patients with senile brain disease (including 2 with parkinsonian symptoms) were treated with amantadine in an oral dosage of 200--300 mg daily." | 5.26 | Amantadine in senile dementia: electroencephalographic and clinical effects. ( Boillat, J; Cole, M; Dastoor, DP; Klingner, A; Müller, HF, 1979) |
| "Amantadine was not superior to placebo." | 2.72 | Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial. ( Garssen, MP; Jacobs, BC; Merkies, IS; Schmitz, PI; van der Meché, FG; van Doorn, PA, 2006) |
| "Nortriptyline was reported in one study as superior for men with alcohol dependency on mean number of drinking days and on alcohol dependence, but not for severity of alcohol misuse or on the patient's or clinician's rating of drinking." | 2.46 | Pharmacological interventions for antisocial personality disorder. ( Duggan, C; Ferriter, M; Huband, N; Khalifa, N; Lieb, K; Stoffers, J; Völlm, BA, 2010) |
| "Amantadine treatment also reduces the production of NO and metabolism of GABA." | 1.56 | Amantadine exerts anxiolytic like effect in mice: Evidences for the involvement of nitrergic and GABAergic signaling pathways. ( Garg, C; Garg, M; Walia, V, 2020) |
| "Nineteen patients with senile brain disease (including 2 with parkinsonian symptoms) were treated with amantadine in an oral dosage of 200--300 mg daily." | 1.26 | Amantadine in senile dementia: electroencephalographic and clinical effects. ( Boillat, J; Cole, M; Dastoor, DP; Klingner, A; Müller, HF, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Walia, V | 1 |
| Garg, C | 1 |
| Garg, M | 1 |
| Khalifa, NR | 1 |
| Gibbon, S | 1 |
| Völlm, BA | 2 |
| Cheung, NH | 1 |
| McCarthy, L | 1 |
| Khalifa, N | 1 |
| Duggan, C | 1 |
| Stoffers, J | 1 |
| Huband, N | 1 |
| Ferriter, M | 1 |
| Lieb, K | 1 |
| Fleminger, S | 2 |
| Greenwood, RJ | 2 |
| Oliver, DL | 2 |
| Stryjer, R | 1 |
| Strous, RD | 1 |
| Shaked, G | 1 |
| Bar, F | 1 |
| Feldman, B | 1 |
| Kotler, M | 1 |
| Polak, L | 1 |
| Rosenzcwaig, S | 1 |
| Weizman, A | 1 |
| Garssen, MP | 1 |
| Schmitz, PI | 1 |
| Merkies, IS | 1 |
| Jacobs, BC | 1 |
| van der Meché, FG | 1 |
| van Doorn, PA | 1 |
| McFarland, HR | 1 |
| Müller, HF | 1 |
| Dastoor, DP | 1 |
| Klingner, A | 1 |
| Cole, M | 1 |
| Boillat, J | 1 |
| Sulcová, A | 1 |
| Gulda, O | 1 |
| Holmsen, R | 1 |
| Barbieri, NF | 1 |
| Megna, GF | 1 |
| Micalizzi, V | 1 |
| Pigneri, MT | 1 |
| Puca, FM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Fluoxetine on Measures of Domestic Violence[NCT00011765] | Phase 2 | 104 participants (Actual) | Interventional | 2001-02-22 | Completed | ||
| Medication Development for Cocaine Dependence[NCT00249691] | Phase 3 | 180 participants (Anticipated) | Interventional | 2005-10-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for amantadine and Anxiety
| Article | Year |
|---|---|
Pharmacological interventions for antisocial personality disorder.
Topics: Adult; Aggression; Alcohol-Related Disorders; Amantadine; Antisocial Personality Disorder; Anxiety; | 2020 |
Pharmacological interventions for antisocial personality disorder.
Topics: Adult; Aggression; Alcohol-Related Disorders; Amantadine; Antisocial Personality Disorder; Anxiety; | 2020 |
Pharmacological interventions for antisocial personality disorder.
Topics: Adult; Aggression; Alcohol-Related Disorders; Amantadine; Antisocial Personality Disorder; Anxiety; | 2020 |
Pharmacological interventions for antisocial personality disorder.
Topics: Adult; Aggression; Alcohol-Related Disorders; Amantadine; Antisocial Personality Disorder; Anxiety; | 2020 |
Pharmacological interventions for antisocial personality disorder.
Topics: Adult; Aggression; Alcohol-Related Disorders; Amantadine; Antisocial Personality Disorder; Anxiety; | 2010 |
Pharmacological management for agitation and aggression in people with acquired brain injury.
Topics: Adrenergic beta-Antagonists; Aggression; Amantadine; Anxiety; Brain Injuries; Humans; Methylphenidat | 2003 |
Pharmacological management for agitation and aggression in people with acquired brain injury.
Topics: Adrenergic beta-Antagonists; Aggression; Amantadine; Anxiety; Brain Injuries; Humans; Methylphenidat | 2006 |
2 trials available for amantadine and Anxiety
| Article | Year |
|---|---|
Amantadine as augmentation therapy in the management of treatment-resistant depression.
Topics: Adult; Aged; Amantadine; Antidepressive Agents; Anxiety; Depressive Disorder; Dopamine Agonists; Dos | 2003 |
Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial.
Topics: Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Anxiety; Cross-Over Studies; Depressio | 2006 |
6 other studies available for amantadine and Anxiety
| Article | Year |
|---|---|
Amantadine exerts anxiolytic like effect in mice: Evidences for the involvement of nitrergic and GABAergic signaling pathways.
Topics: Amantadine; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Brain; Diazepam; Disease Models | 2020 |
Treating parkinsonism in the era of levodopa.
Topics: Amantadine; Antidepressive Agents; Anxiety; Depression; Histamine H1 Antagonists; Humans; Levodopa; | 1975 |
Amantadine in senile dementia: electroencephalographic and clinical effects.
Topics: Administration, Oral; Aged; Amantadine; Anxiety; Dementia; Depression; Electroencephalography; Femal | 1979 |
The behavioural effects of benzodiazepine receptor ligands in mice are inhibited by adamantylamide dipeptide.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Anxiety; Behavior, Animal; Carbolines; Diazepam; Dipept | 1989 |
[Amantadine treatment in parkinsonism].
Topics: Administration, Oral; Amantadine; Anxiety; Hallucinations; Humans; Parkinson Disease; Sleep Wake Dis | 1973 |
[Preliminary psychological findings during treatment of the parkinsonian syndrome with amantadine. Preliminary observations].
Topics: Amantadine; Anxiety; Depression; Dihydroxyphenylalanine; Emotions; Humans; Intelligence Tests; Menta | 1971 |